Skip to content
StockMarketAgent
Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

CTEV stock hub

Claritev Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CTEVis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
460.3M
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
CTEV
In the news

Latest news · CTEV

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E4.7
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROEn/a
P25 -105.6P50 -46.5P75 -3.1
ROIC2
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CTEV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
210
Groups with data
11
Currency
USD
Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001793229
Company name
Claritev Corporation
Country
United States
Country code
US
Cusip
62548M209
Employees
3,000
Employees Change
300%
Employees Change Percent
11.11
Enterprise value
$5.2B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
Industry
Health Information Services
Isin
US62548M2098
Last refreshed
2026-05-10
Market cap
$460.3M
Market cap category
Small-Cap
Price
$27
Price currency
USD
Rev Per Employee
326,253.67x
Sector
Healthcare
Sic
7389
Symbol
CTEV
Website
https://www.claritev.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-62.25%
EV Sales Forward
5.07x
EV/EBIT
59.27x
EV/EBITDA
9.71x
EV/Sales
5.29x
FCF yield
-7.8%
Forward P/E
4.67x
P/S ratio
0.47x
PS Forward
0.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
8.92%
EBITDA Margin
54.49%
Gross margin
73.23%
Gross Profit
$716.7M
Gross Profit Growth
4.22%
Gross Profit Growth Q
2.75%
Gross Profit Growth3 Y
-3.85%
Gross Profit Growth5 Y
2.71%
Net Income
$-286.5M
Net Income Growth Years
1%
Pretax Margin
-38.41%
Profit Margin
-29.27%
Profit Per Employee
$-95,508
ROA
1.1
Roa5y
1.88
ROCE
1.88
ROIC
1.96
Roic5y
3.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr1y
27.2%
Cagr3y
-5.1%
Cagr5y
-37.35%
EPS Growth Years
1
OCF Growth
264.89%
OCF Growth3 Y
-25.09%
OCF Growth5 Y
-24.01%
Revenue Growth
5.53x
Revenue Growth Q
5.77x
Revenue Growth Quarters
4x
Revenue Growth Years
1x
Revenue Growth3 Y
-1.31x
Revenue Growth5 Y
0.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
$0.2
Assets
$4.8B
Cash
$21.3M
Current Assets
$242.3M
Current Liabilities
$189.6M
Debt
$4.7B
Debt EBITDA
$8.81
Equity
$-234.4M
Interest Coverage
0.22
Liabilities
$5.1B
Long Term Assets
$4.6B
Long Term Liabilities
$4.9B
Net Cash
$-4.7B
Net Cash By Market Cap
$-1,025
Net Debt EBITDA
$8.84
Tangible Book Value
$-4.4B
Tangible Book Value Per Share
$-262
WACC
6.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.28
Net Working Capital
$54.7M
Quick ratio
0.93
Working Capital
$52.7M
Working Capital Turnover
$34.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-2.25%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
27.18%
200-day SMA
40.02
3Y total return
-14.55%
50-day SMA
18.9
50-day SMA vs 200-day SMA
50under200
5Y total return
-90.34%
All Time High
517.2
All Time High Change
-94.78%
All Time High Date
2020-07-13
All Time Low
4.8
All Time Low Change
462.5%
All Time Low Date
2024-11-19
ATR
2.11
Beta
0.77
Beta1y
3.09
Beta2y
1.91
Ch YTD
-36.84
High
27.17
High52
74.07
High52 Date
2025-09-08
High52ch
-63.55%
Low
22.88
Low52
12.04
Low52 Date
2026-02-25
Low52ch
124.25%
Ma50ch
42.86%
Price vs 200-day SMA
-32.54%
RSI
66.52
RSI Monthly
44.26
RSI Weekly
48.18
Sharpe ratio
0.75x
Sortino ratio
1.13
Total Return
-2.25%
Tr YTD
-36.84
Tr1m
59.57%
Tr1w
8.3%
Tr3m
4.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

12
MetricValue
Analyst Count
5
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$0.34
Earnings Revenue Estimate
238,248,000x
Earnings Revenue Estimate Growth
2.99x
Operating Income
$87.3M
Operating Income Growth
-9.75
Operating Income Growth Q
-12.63
Operating Income Growth3 Y
-30.75
Operating margin
8.92
Price target
$39
Price Target Change
$44.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
5,819,129%
Float Percent
34.13%
Net Borrowing
30,311,000
Shares Insiders
8.27%
Shares Institutions
31.84%
Shares Out
17,047,789
Shares Qo Q
1%
Shares Yo Y
2.25%
Short Float
21.2%
Short Ratio
10.96
Short Shares
7.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
$-64.3M
Average Volume
87,818x
Bv Per Share
-14.18
CAPEX
$-137.5M
Ch1m
59.57
Ch1w
8.3
Ch1y
27.18
Ch3m
4.21
Ch3y
-14.55
Ch5y
-90.34
Ch6m
-61.01
Change
11.52%
Change From Open
10.47
Close
24.21
Days Gap
0.95
Depreciation Amortization
446,000,000
Dollar Volume
4,566,942
Earnings Date
2026-05-07
Earnings Time
bmo
EBIT
$87.3M
EBITDA
$533.3M
EPS
$-17.33
F Score
5
FCF
$-35.9M
FCF EV Yield
-0.69x
FCF Per Share
$-2.11
Financing CF
28,146,000
Fiscal Year End
December
Founded
1,980
Goodwill
2,405,853,000
Income Tax
$-89.4M
Investing CF
-128,919,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Date
2024-09-23
Last Split Type
Reverse
Last10k Filing Date
2026-02-26
Ma150
34.01
Ma150ch
-20.61%
Ma20
22.69
Ma20ch
18.98%
Net CF
828,000
Next Earnings Date
2026-08-05
Open
24.44
Optionable
Yes
P OCF Ratio
4.53
Position In Range
96.04
Ppne
357,148,000
Price Date
2026-05-08
Price EBITDA
$0.86
Relative Volume
1.93x
Revenue
978,761,000x
SBC By Revenue
2.9x
Share Based Comp
28,388,000
Tax By Revenue
-9.13x
Tr6m
-61.01%
Us State
Virginia
Volume
169,146
Z Score
-0.37
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CTEV pay a dividend?

Capital-return profile for this ticker.

Performance

CTEV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+27.2%
S&P 500 1Y: n/a
3Y total return
-14.5%
S&P 500 3Y: n/a
5Y total return
-90.3%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CTEV?

Insider, institutional, and short-interest positioning.

Institutional ownership
+31.8%
Float: +34.1% of shares outstanding
Insider ownership
+8.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+21.2%
11.0 days to cover
Y/Y dilution
+2.2%
Negative means the company is buying back shares.
Technical

CTEV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
66.5
Neutral momentum band
Price vs 200-day MA
-32.5%
50/200-day relationship not available
Beta (5Y)
0.77
Less volatile than the market
Sharpe ratio
0.75
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CTEV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CTEV stock rating?

Claritev Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CTEV analysis?

The full report lives at /stocks/CTEV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CTEV?

The latest report frames CTEV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CTEV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.